Cytokinetics (CYTK) Shares Outstanding (Weighted Average) (2016 - 2025)
Historic Shares Outstanding (Weighted Average) for Cytokinetics (CYTK) over the last 16 years, with Q3 2024 value amounting to $117685.0.
- Cytokinetics' Shares Outstanding (Weighted Average) rose 2249.79% to $117685.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $117685.0, marking a year-over-year increase of 2249.79%. This contributed to the annual value of $96524.0 for FY2023, which is 745.78% up from last year.
- According to the latest figures from Q3 2024, Cytokinetics' Shares Outstanding (Weighted Average) is $117685.0, which was up 2249.79% from $109240.0 recorded in Q2 2024.
- In the past 5 years, Cytokinetics' Shares Outstanding (Weighted Average) registered a high of $117685.0 during Q3 2024, and its lowest value of $59270.0 during Q1 2020.
- In the last 5 years, Cytokinetics' Shares Outstanding (Weighted Average) had a median value of $85731.0 in 2022 and averaged $85185.0.
- As far as peak fluctuations go, Cytokinetics' Shares Outstanding (Weighted Average) soared by 246.7% in 2023, and later surged by 2249.79% in 2024.
- Cytokinetics' Shares Outstanding (Weighted Average) (Quarter) stood at $64524.0 in 2020, then grew by 19.16% to $76886.0 in 2021, then increased by 16.83% to $89825.0 in 2022, then increased by 7.46% to $96524.0 in 2023, then increased by 21.92% to $117685.0 in 2024.
- Its Shares Outstanding (Weighted Average) stands at $117685.0 for Q3 2024, versus $109240.0 for Q2 2024 and $101924.0 for Q1 2024.